A urine-based DNA methylation assay, ProCUrE, to identify clinically significant prostate cancer

Zhao, F; Olkhov-Mitsel, E; Kamdar, S; Jeyapala, R; Garcia, J; Hurst, R; Hanna, Y; ... Bapat, B; + view all Zhao, F; Olkhov-Mitsel, E; Kamdar, S; Jeyapala, R; Garcia, J; Hurst, R; Hanna, Y; Mills, R; Tuzova, AV; O'Reilly, E; Kelly, S; Cooper, C; The Movember Urine Biomarker Consortium, ; Brewer, D; Perry, AS; Clark, J; Fleshner, N; Bapat, B; - view fewer (2018) A urine-based DNA methylation assay, ProCUrE, to identify clinically significant prostate cancer. Clinical Epigenetics , 10 , Article 147. 10.1186/s13148-018-0575-z . Green open access

http://bit.ly/2Gx124r